IMNN
ImunonBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
The best bull argument is that IMNN-001 has reinforcing company-source support across final Phase 2 survival data, FDA protocol alignment, and ahead-of-plan Phase 3 enrollment commentary, which together keep the lead asset credible despite the tiny equity value [#SEC-8K-2026-03-31][#SEC-8K-2026-05-12].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Coverage remains thin: there is little trustworthy analyst-revision evidence in the packet, which limits confidence in how broadly the March, May, and June updates have been validated by the Street.
Momentum
93
Value
41
Sentiment
53
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.90 · Bull $3.20 · Bear $1.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-24 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $15.00
Why
Momentum93 · Δ7d -
Value41 · Δ7d -0.1
Sentiment53 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
93
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
53
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 93.5 / Value 41.1 / Sentiment 52.6
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$7.69M
Beta
2.13
Shares Out
4.2M
P/E (TTM) · Derived
-0.3
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.34
Rev YoY
-100.0%
EPS YoY
-77.0%
Gross Margin
-387.2%
Op Margin
-
Net Debt
-$7.77M
Current Ratio
1.59
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology